Search results
Author(s):
Rasha Al-Lamee
,
Christopher Rajkumar
,
Nazli Okumus
Added:
4 months ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA…
View more
Author(s):
Philip A Poole-Wilson
Added:
3 years ago
Introduction
Coronary heart disease (CHD), due to atheromatous obstruction of coronary arteries, is the most common form of heart disease. The atheroma forms and accumulates in the wall of the coronary artery (coronary atherosclerosis) beginning at an early age. The disease is thought to be initiated by damage to the endothelium - the inner lining of the vessel wall - as a consequence of a…
View more
Author(s):
Philip A Poole-Wilson
Added:
3 years ago
Introduction
Coronary heart disease (CHD), due to atheromatous obstruction of coronary arteries, is the most common form of heart disease. The atheroma forms and accumulates in the wall of the coronary artery (coronary atherosclerosis) beginning at an early age. The disease is thought to be initiated by damage to the endothelium - the inner lining of the vessel wall - as a consequence of a…
View more
Author(s):
Gaetano Antonio Lanza
Added:
3 years ago
Up to 50% of patients who undergo elective coronary angiography for stable chest pain symptoms that are mainly related to exercise and typical enough to suggest the presence of obstructive coronary artery disease (CAD) are found to have normal or near-normal coronary arteries.1 The mechanisms responsible for angina chest pain in these patients are heterogeneous; accordingly, their identification…
View more
Author(s):
Jason M Tarkin
,
Juan Carlos Kaski
Added:
3 years ago
Stable angina pectoris is the most prevalent clinical manifestation of coronary heart disease. While the overall prognosis in patients with stable angina is good, with a low yearly event rate of ~1–2 %,1 for many, adequate symptom control can be difficult to achieve, leading to significantly impaired quality of life.
The traditional approach to the pharmacological management of stable angina, as…
View more
Author(s):
Marie Mide Michelsen
,
Naja Dam Mygind
,
Daria Frestad
,
et al
Added:
3 years ago
Women have for many years been regarded as being at relatively low risk for the development of ischaemic heart disease (IHD).1,2 Recently this pattern has changed and cardiovascular disease (CVD) is now the leading cause of death for women in Europe.3,4 Under the age of 60 years acute coronary syndrome occurs 3–4 times more often in men; however, after the age of 75 years women represent the…
View more
Stable Angina Medical Therapy
Author(s):
Talla A Rousan
,
Udho Thadani
Added:
3 years ago
Article
Author(s):
Kevin Cheng
,
Paul Sainsbury
,
Michael Fisher
,
et al
Added:
3 years ago
Refractory angina (RA) is conventionally defined as a chronic condition (≥3 months in duration) characterised by angina in the setting of coronary artery disease (CAD), which cannot be controlled by a combination of optimal medical therapy, angioplasty or bypass surgery, and where reversible myocardial ischaemia has been clinically established to be the cause of the symptoms.1
In clinical…
View more